Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
By G. Genovese, D. Friedman, M. D. Ross, L. Lecordier, Pierrick Uzureau, B. Freedman, D. Bowden, Carl D. Langefeld, Taras K. Oleksyk, Andrea L Uscinski Knob and 8 more. 2010
1,942 citations recorded by the source corpus.
Out of Africa Kidney disease is more common in African Americans than in Americans of European descent, and genetics is likely to be a major contributing factor. Genovese et al. (p. 841, published online 15 July) now show that African Americans who carry specific sequence variants in a gene on chromosome 22 encoding apolipoprotein L-1 (APOL1) have an increased risk of developing hypertension-attributed end-stage kidney disease or focal segmental glomerulosclerosis. These variants are absent from European chromosomes. Among the functions ascribed to APOL1 is the ability to lyse and kill trypanosomes. Intriguingly, APOL1 derived from the risk alleles, but not the “wild-type” allele, killed Trypanosoma brucei rhodesiense, which causes African sleeping sickness. Genetic variants associated with kidney disease in African Americans may confer protection against trypanosomes. African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease–associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.
Subfields: Epidemiology, Genetics, Nephrology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Genetics
In Nephrology
- A. Levey
- Josef Coresh
- Marcello Tonelli
- Harold I. Feldman
- A. Levin
- K. Matsushita
- R. Gansevoort
- Giuseppe Remuzzi
Citations in the corpus
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association (2019, background): “MPOWER policies outline the following strategies for nations to reduce tobacco use: (1) monitor tobacco use and prevention policies; (2) protect individuals from tobacco smoke; (3) offer to help with tobacco cessation; (4) warn about tobacco-related dangers; (5) enforce bans on tobacco advertising; ”
- Genetics and pathogenesis of inflammatory bowel disease (2011, background): “For example, variants of apolipoprotein L1 and the inhibitory Fc receptor FcγRIIb that confer protection against trypanosomiasis and malaria, respectively, are more common in populations endemically exposed to these pathogens, but these variants also confer increased susceptibility to focal segmenta”
- Focal Segmental Glomerulosclerosis. (2017, background): “More recently, efforts to identify genetic drivers of FSGS in at-risk populations have gained momentum, with the most recent addition including the APOL1 genetic variant as a major association with FSGS in individuals of sub-Saharan African descent with FSGS (23).”
- An Unexpectedly Complex Architecture for Skin Pigmentation in Africans (2017, neutral): “, approximately hundreds of individuals) compared to common diseases (Genovese et al., 2010; Kenny et al., 2012; Yi et al., 2010).”
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “Page 30 of 83 trypanosomiasis that correspond to higher rates of ESRD in individuals of African ancestry.(133,199)”
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, background): “Similar findings have been reported recently in the Southern Community Cohort Jacobson et al NLA Dyslipidemia Recommendations - Part 2 S9 Study of low socioeconomic status AAs.38 Participants with the healthiest diets (in the top one-fifth of the Healthy Eating Index 2010 score) had approximately 20”